Elsy Boglioli Hofman

Ms. Elsy Boglioli Hofman is an Independent Director at FTI Consulting, Inc., a Chairman at Threefrog Therapeutics, an Independent Director at Gensight Biologics SA, a Chief Executive Officer at Bio-Up, an Advisor at BlueStone Venture Partners LLC and a Chief Strategy Officer & Director at Laverock Therapeutics Ltd. She is on the Board of Directors at Mauna Kea Technologies SA, FTI Consulting, Inc., Wolf-Medizintechnik GmbH, Inpart SAS, Gensight Biologics SA, METAFORA Biosystems SAS and Laverock Therapeutics Ltd. Ms. Boglioli Hofman was previously employed as an Independent Director by OSE Immunotherapeutics SA, a Chief Operating Officer by Cellectis SA, and a Managing Director & Partner by Boston Consulting Group SAS. She received her undergraduate degree from Ecole Polytechnique and a graduate degree from Universitat Pompeu Fabra.